MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
7.03
+0.01
+0.14%
After Hours: 7.08 +0.05 +0.70% 19:51 05/22 EDT
OPEN
7.11
PREV CLOSE
7.02
HIGH
7.27
LOW
7.01
VOLUME
266.45K
TURNOVER
--
52 WEEK HIGH
24.17
52 WEEK LOW
5.85
MARKET CAP
199.81M
P/E (TTM)
-2.4965
1D
5D
1M
3M
1Y
5Y
1D
Arcturus Therapeutics’ Earnings Call: mRNA Bets vs. Burn
TipRanks · 3d ago
Weekly Report: what happened at ARCT last week (0511-0515)?
Weekly Report · 4d ago
ARCT Rating Reiterated at Hold as High-Risk ARCT-032 CF Program Awaits Binary Phase 2 Readout; $9 Price Target Maintained
TipRanks · 05/13 10:36
Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Arcturus Therapeutics (ARCT) and Waters (WAT)
TipRanks · 05/11 12:03
Weekly Report: what happened at ARCT last week (0504-0508)?
Weekly Report · 05/11 10:27
Arcturus Therapeutics Signals Progress Amid Revenue Slip
TipRanks · 05/09 01:17
Myles Minter Reiterates Buy on Arcturus, Citing Strengthened CF Pipeline, Reduced Competitive Pressure, and Rare-Disease Upside
TipRanks · 05/08 10:48
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT), Celldex (CLDX) and Collegium Pharmaceutical (COLL)
TipRanks · 05/08 10:41
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

Webull offers Arcturus Therapeutics Holdings Inc stock information, including NASDAQ: ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.